Marika Cordaro

Prof. Marika Cordaro

Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina,
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2017 in Antioxidants & Redox Signaling
Verified
Journal Article
Open access
MCMichela Campolo
Michela Campolo
GCGiovanna Casili
Giovanna Casili
FBFlavia Biundo
Flavia Biundo
Rosalia CrupiRosalia Crupi
Rosalia Crupi
Marika CordaroMarika Cordaro
Marika Cordaro
Emanuela EspositoEmanuela Esposito
Emanuela Esposito
Aim: Oxidative stress plays a key role in Parkinson disease (PD), and nuclear transcription factor related to NF-E2 (Nrf-2) is involved in neuroprotection against PD. The aim of the present study was to investigate a role for nuclear factor-κB (NF-κB)/Nrf-2 in the neurotherapeutic action of dimethyl fumarate (DMF) in a mouse model of PD and in vitro in SHSY-5Y cells. Results: Daily oral gavage of DMF (10, 30, and 100 mg/kg) significantly reduced neuronal cell degeneration of the dopaminergic tract and behavioral impairments induced by four injections of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Moreover, treatment with DMF prevented dopamine depletion, increased tyrosine hydroxylase and dopamine transporter activities, and also reduced the number of α-synuclein-positive neurons. Furthermore, DMF treatment upregulated the Nrf-2 pathway, increased NeuN + /Nrf-2 + cell number in the striatum, induced activation of manganese superoxide dismutase and heme oxygenase-1, and regulated glutathione levels. Moreover, DMF reduced interleukin 1 levels, cyclooxygenase 2 activity, and nitrotyrosine neuronal nitrite oxide synthase expression. This treatment also modulated microglia activation, restored nerve growth factor levels, and preserved microtubule-associated protein 2 alterations. The protective effects of DMF treatment, via Nrf-2, were confirmed in in vitro studies, through inhibition of Nrf-2 by trigonelline. Innovation: These findings demonstrate that DMF, both in a mouse model of PD and in vitro , provides, via regulation of the NF-κB/Nrf-2 pathway, novel cytoprotective modalities that further augment the natural antioxidant response in neurodegenerative and inflammatory disease models. Conclusion: These results support the thesis that DMF may constitute a promising therapeutic target for the treatment of PD. Antioxid. Redox Signal. 27, 453–471.

28 August 2014 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
Daniela ImpellizzeriDaniela Impellizzeri
Daniela Impellizzeri
GBGiuseppe Bruschetta
Giuseppe Bruschetta
Marika CordaroMarika Cordaro
Marika Cordaro
Rosalia CrupiRosalia Crupi
Rosalia Crupi
RSRosalba Siracusa
Rosalba Siracusa
Salvatore CuzzocreaSalvatore Cuzzocrea
Salvatore Cuzzocrea
The fatty acid amide palmitoylethanolamide (PEA) has been studied extensively for its anti-inflammatory and neuroprotective actions. The lipidic nature and large particle size of PEA in the native state may limit its solubility and bioavailability when given orally, however. Micronized formulations of a drug enhance its rate of dissolution and reduce variability of absorption when orally administered. The present study was thus designed to evaluate the oral anti-inflammatory efficacy of micronized/ultramicronized versus nonmicronized PEA formulations. Micronized/ultramicronized PEA was produced by the air-jet milling technique, and the various PEA preparations were subjected to physicochemical characterization to determine particle size distribution and purity. Each PEA formulation was then assessed for its anti-inflammatory effects when given orally in the carrageenan-induced rat paw model of inflammation, a well-established paradigm of edema formation and thermal hyperalgesia. Intraplantar injection of carrageenan into the right hind paw led to a marked accumulation of infiltrating inflammatory cells and increased myeloperoxidase activity. Both parameters were significantly decreased by orally given micronized PEA (PEA-m; 10 mg/kg) or ultramicronized PEA (PEA-um; 10 mg/kg), but not nonmicronized PeaPure (10 mg/kg). Further, carrageenan-induced paw edema and thermal hyperalgesia were markedly and significantly reduced by oral treatment with micronized PEA-m and ultramicronized PEA-um at each time point compared to nonmicronized PeaPure. However, when given by the intraperitoneal route, all PEA formulations proved effective. These findings illustrate the superior anti-inflammatory action exerted by orally administered, micronized PEA-m and ultramicronized PEA-um, versus that of nonmicronized PeaPure, in the rat paw carrageenan model of inflammatory pain.

Verified
Journal Article
Open access
PDF file
GFGianluca Antonio Franco
Gianluca Antonio Franco
LILivia Interdonato
Livia Interdonato
Marika CordaroMarika Cordaro
Marika Cordaro
Salvatore CuzzocreaSalvatore Cuzzocrea
Salvatore Cuzzocrea
RPRosanna Di paola
Rosanna Di paola
Neurodegenerative disorders are a widespread cause of morbidity and mortality worldwide, characterized by neuroinflammation, oxidative stress, and neuronal depletion. They include selective malfunction and progressive loss of neurons, glial cells, and neural networks in the brain and spinal cord. There is an urgent need to develop new and more effective therapeutic strategies to combat these devastating diseases because, today, there is no treatment that can cure degenerative diseases; however, we have many symptomatic treatments. Current nutritional approaches are beginning to reflect a fundamental change in our understanding of health. The Mediterranean diet may have a protective effect on the neurodegenerative process because it is rich in antioxidants, fiber, and omega-3 polyunsaturated fatty acids. Increasing knowledge regarding the impact of diet on regulation at the genetic and molecular levels is changing the way we consider the role of nutrition, resulting in new dietary strategies. Natural products, thanks to their bioactive compounds, have recently undergone extensive exploration and study for their therapeutic potential for a variety of diseases. Targeting simultaneous multiple mechanisms of action and a neuroprotection approach with the diet could prevent cell death and restore function to damaged neurons. For these reasons, this review will be focused on the therapeutic potential of natural products and the associations between the Mediterranean-style diet (MD), neurodegenerative diseases, and markers and mechanisms of neurodegeneration.

4 October 2016 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
PDF file
BBBartolomeo Bertolino
Bartolomeo Bertolino
Rosalia CrupiRosalia Crupi
Rosalia Crupi
Daniela ImpellizzeriDaniela Impellizzeri
Daniela Impellizzeri
GBGiuseppe Bruschetta
Giuseppe Bruschetta
Marika CordaroMarika Cordaro
Marika Cordaro
Salvatore CuzzocreaSalvatore Cuzzocrea
Salvatore Cuzzocrea
Summary: Aims: Autism spectrum disorder (ASD) is a condition defined by social communication deficits and repetitive restrictive behaviors. Association of the fatty acid amide palmitoylethanolamide (PEA) with the flavonoid luteolin displays neuroprotective and antiinflammatory actions in different models of central nervous system pathologies. We hypothesized that association of PEA with luteolin might have therapeutic utility in ASD, and we employed a well‐recognized autism animal model, namely sodium valproate administration, to evaluate cognitive and motor deficits.Methods: Two sets of experiments were conducted. In the first, we investigated the effect of association of ultramicronized PEA with luteolin, co‐ultramicronized PEA‐LUT® (co‐ultraPEA‐LUT®) in a murine model of autistic behaviors, while in the second, the effect of co‐ultraPEA‐LUT® in a patient affected by ASD was examined.Results: Co‐ultraPEA‐LUT® treatment ameliorated social and nonsocial behaviors in valproic acid‐induced autistic mice and improved clinical picture with reduction in stereotypes in a 10‐year‐old male child.Conclusion: These data suggest that ASD symptomatology may be improved by agents documented to control activation of mast cells and microglia. Co‐ultraPEA‐LUT® might be a valid and safe therapy for the symptoms of ASD alone or in combination with other used drugs.

20 March 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
RSRosalba Siracusa
Rosalba Siracusa
Roberta FuscoRoberta Fusco
Roberta Fusco
APAlessio Filippo Peritore
Alessio Filippo Peritore
Marika CordaroMarika Cordaro
Marika Cordaro
RDRamona D'Amico
Ramona D'Amico
Daniela ImpellizzeriDaniela Impellizzeri
Daniela Impellizzeri
Background: Anacardium occidentale L. is a tropical plant used for the treatment of inflammatory diseases. The goal of the present work was to investigate the anti-inflammatory and anti-oxidant potential of oral administration of cashew nuts (from Anacardium occidentale L.) in a mouse model of colitis. Methods: Induction of colitis was performed by intrarectally injection of dinitrobenzene sulfonic acid (DNBS). Cashew nuts were administered daily orally (100 mg/kg) in DNBS-injected mice. Results: Four days after DNBS, histological and macroscopic colon alterations as well as marked clinical signs and increased cytokine production were observed. Neutrophil infiltration, measured by myeloperoxidase (MPO) positive immunostaining, was correlated with up-regulation of adhesion molecules ICAM-1 and P-selectin in colons. Oxidative stress was detected with increased malondialdehyde (MDA) levels, nitrotyrosine, and poly ADP-ribose polymerase (PARP) positive staining in inflamed colons. Oral treatment with cashew nuts reduced histological, macroscopic damage, neutrophil infiltration, pro-inflammatory cytokines and MDA levels, as well as nitrotyrosine, PARP and ICAM-1, and P-selectin expressions. Colon inflammation could be related to nuclear factor (NF)-kB pathway activation and reduced manganese superoxide dismutase (MnSOD) antioxidant activity. Cashew nuts administration inhibited NF-kB and increased MnSOD antioxidant expressions. Conclusions: The results suggested that oral assumption of cashew nuts may be beneficial for the management of colitis.

12 August 2015 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
Daniela ImpellizzeriDaniela Impellizzeri
Daniela Impellizzeri
ETElena Talero
Elena Talero
RSRosalba Siracusa
Rosalba Siracusa
AAAntonio Alcaide
Antonio Alcaide
Marika CordaroMarika Cordaro
Marika Cordaro
VMVirginia Motilva
Virginia Motilva
Polyphenols have been described to have a wide range of biological activities, and many reports, published during recent years, have highlighted the beneficial effects of phenolic compounds, illustrating their promising role as therapeutic tools in several acute and chronic disorders. The purpose of study was to evaluate, in an already-assessed model of lung injury caused by bleomycin (BLM) administration, the role of resveratrol and quercetin, as well as to explore the potential beneficial properties of a mango leaf extract, rich in mangiferin, and a grape leaf extract, rich in dihydroquercetin (DHQ), on the same model. Mice were subjected to intra-tracheal administration of BLM, and polyphenols were administered by oral route immediately after BLM instillation and daily for 7 d. Treatment with resveratrol, mangiferin, quercetin and DHQ inhibited oedema formation and body weight loss, as well as ameliorated polymorphonuclear infiltration into the lung tissue and reduced the number of inflammatory cells in bronchoalveolar lavage fluid. Moreover, polyphenols suppressed inducible nitric oxide synthase expression, and prevented oxidative and nitroxidative lung injury, as shown by the reduced nitrotyrosine and poly (ADP-ribose) polymerase levels. The degree of apoptosis, as evaluated by Bid and Bcl-2 balance, was also suppressed after polyphenol treatment. Finally, these natural products down-regulated cyclo-oxygenase-2, extracellular signal-regulated kinase phosphorylated expression and reduced NF-κBp65 translocation. Our findings confirmed the anti-inflammatory effects of resveratrol and quercetin in BLM-induced lung damage, and highlight, for the first time, the protective properties of exogenous administration of mangiferin and DHQ on experimental pulmonary fibrosis.